Impotence gel would rival Viagra

Jul 05, 2006
Viagra pill

A British-based pharmaceutical company says it plans to introduce an impotence gel that would rival Viagra.

The non-prescription gel -- to enter into clinical trials later this year -- is designed to be applied directly to the penis for the treatment of erectile dysfunction, The Times of London reported.

The gel -- being developed by Britain's Futura Medical Plc in collaboration with GlaxoSmithKline in the United States -- would compete with Pfizer Inc.'s Viagra in the multi-billion dollar anti-impotence market, the newspaper said.

The product is based on glyceryl trinitrate, currently used to treat angina. Viagra was also originally developed as a heart drug, but during clinical trials was found to be effective in treating erectile dysfunction. Viagra has been prescribed to more than 23 million men worldwide since it was introduced in 1998.

About 1,500 men are expected to be recruited into three clinical trials of the gel that, if given regulatory approval, would be available by 2009, the Times reported, noting the trials will also involve the study of its effects on women who would come into contact with the gel during sex.

Copyright 2006 by United Press International

Explore further: Obama offers new accommodations on birth control

add to favorites email to friend print save as pdf

Related Stories

Giant tablets aimed at families

45 minutes ago

Costing a little more than an iPad but standing more than twice as tall, a new pair of giant tablets wants families to share cozier group experiences with technology.

Restaurants experimenting with pay-in-advance tickets

2 hours ago

With restaurant patrons increasingly jumping on the Internet to make reservations, some high-end eateries here and across the country are adding a new tech wrinkle: having their clientele pay for their meal in advance using ...

Recommended for you

Obama offers new accommodations on birth control

21 minutes ago

The Obama administration will offer a new accommodation to religious nonprofits that object to covering birth control for their employees. The measure allows those groups to notify the government, rather than their insurance ...

New enzyme targets for selective cancer therapies

45 minutes ago

Thanks to important discoveries in basic and clinical research and technological advances, the fight against cancer has mobilized into a complex offensive spanning multiple fronts.

Towards renal artery stenosis treatment

47 minutes ago

Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations for renal artery stenosis e-published in ...

User comments : 0